Table 1.
Characteristics of Participants Who Completed the Study
| All completers | CSII | MDI | |||
|---|---|---|---|---|---|
| Mean ± SD | Min | Max | Mean ± SD | ||
| Age | 37 ± 11 | 17 | 57 | 40.6 ± 11.1 | 29.8 ± 6.9 |
| T1DM duration | 21 ± 11.1 | 1 | 45 | 24.4 ± 9.7 | 14.3 ± 11 |
| HbA1c | 7.2 ± 1 | 5.3 | 9.7 | 7.4 ± 0.9 | 6.9 ± 1.2 |
| Height | 172 ± 10.7 | 155.2 | 194.1 | 172.1 ± 11.9 | 171.8 ± 8.7 |
| Weight | 81.8 ± 19.9 | 51.4 | 130.1 | 84.9 ± 20.1 | 75.7 ± 19.3 |
| BMI | 27.4 ± 4.6 | 19.5 | 35.8 | 28.4 ± 4.4 | 25.4 ± 4.8 |
| TDI | 46.7 ± 22.3 | 12 | 89 | 49.9 ± 17.2 | 40.5 ± 30.4 |
| Pump/MDI | 16 CSII & 8 MDI | ||||
| gender (M/F) | 15 women and 9 men | ||||
BMI, body mass index; CSII, continuous subcutaneous insulin infusion; HbA1c, hemoglobin A1c; MDI, multiple daily injection; SD, standard deviation; T1DM, type 1 diabetes mellitus; TDI, total daily insulin.